Literature DB >> 11406166

Recognition of cisplatin adducts by cellular proteins.

M Kartalou1, J M Essigmann.   

Abstract

Cisplatin is a widely used chemotherapeutic agent. It reacts with nucleophilic bases in DNA and forms 1,2-d(ApG), 1,2-d(GpG) and 1,3-d(GpTpG) intrastrand crosslinks, interstrand crosslinks and monofunctional adducts. The presence of these adducts in DNA is through to be responsible for the therapeutic efficacy of cisplatin. The exact signal transduction pathway that leads to cell cycle arrest and cell death following treatment with the drug is not known but cell death is believed to be mediated by the recognition of the adducts by cellular proteins. Here we describe the structural information available for cisplatin and related platinum adducts, the interactions of the adducts with cellular proteins and the implications of these interactions for cell survival.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11406166     DOI: 10.1016/s0027-5107(01)00142-7

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  86 in total

1.  Discrepancy between in vitro and in vivo antitumor effect of a new platinum(II) metallointercalator.

Authors:  Johnny Moretto; Bruno Chauffert; François Ghiringhelli; Janice R Aldrich-Wright; Florence Bouyer
Journal:  Invest New Drugs       Date:  2010-06-10       Impact factor: 3.850

Review 2.  A copper connection to the uptake of platinum anticancer drugs.

Authors:  John L Nitiss
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-21       Impact factor: 11.205

3.  The RecQ4 orthologue Hrq1 is critical for DNA interstrand cross-link repair and genome stability in fission yeast.

Authors:  Lynda M Groocock; John Prudden; J Jefferson P Perry; Michael N Boddy
Journal:  Mol Cell Biol       Date:  2011-11-07       Impact factor: 4.272

4.  Modulation of the anti-cancer efficacy of microtubule-targeting agents by cellular growth conditions.

Authors:  Jay F Dorsey; Melissa L Dowling; Mijin Kim; Ranh Voong; Lawrence J Solin; Gary D Kao
Journal:  Cancer Biol Ther       Date:  2010-05-15       Impact factor: 4.742

5.  Quercetin and hyperthermia modulate cisplatin-induced DNA damage in tumor and normal tissues in vivo.

Authors:  Nada Oršolić; Nikola Car
Journal:  Tumour Biol       Date:  2014-03-29

6.  Global phosphoproteome profiling reveals unanticipated networks responsive to cisplatin treatment of embryonic stem cells.

Authors:  Alex Pines; Christian D Kelstrup; Mischa G Vrouwe; Jordi C Puigvert; Dimitris Typas; Branislav Misovic; Anton de Groot; Louise von Stechow; Bob van de Water; Erik H J Danen; Harry Vrieling; Leon H F Mullenders; Jesper V Olsen
Journal:  Mol Cell Biol       Date:  2011-10-17       Impact factor: 4.272

7.  Towards biomarker-dependent individualized chemotherapy: exploring cell-specific differences in oxaliplatin-DNA adduct distribution using accelerator mass spectrometry.

Authors:  Sang Soo Hah; Paul T Henderson; Kenneth W Turteltaub
Journal:  Bioorg Med Chem Lett       Date:  2010-03-07       Impact factor: 2.823

8.  Functional uncoupling of MCM helicase and DNA polymerase activities activates the ATR-dependent checkpoint.

Authors:  Tony S Byun; Marcin Pacek; Muh-ching Yee; Johannes C Walter; Karlene A Cimprich
Journal:  Genes Dev       Date:  2005-04-15       Impact factor: 11.361

9.  Differential recognition by the tumor suppressor protein p53 of DNA modified by the novel antitumor trinuclear platinum drug BBR3464 and cisplatin.

Authors:  Jana Kasparkova; Miroslav Fojta; Nicholas Farrell; Viktor Brabec
Journal:  Nucleic Acids Res       Date:  2004-10-14       Impact factor: 16.971

10.  Platinum complexes with imino ethers or cyclic ligands mimicking imino ethers: synthesis, in vitro antitumour activity, and DNA interaction properties.

Authors:  Francesco P Intini; Angelina Boccarelli; Valentina C Francia; Concetta Pacifico; Maria F Sivo; Giovanni Natile; Domenico Giordano; Pietro De Rinaldis; Mauro Coluccia
Journal:  J Biol Inorg Chem       Date:  2004-07-06       Impact factor: 3.358

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.